Investigator Award proposals ($270,000, two years) are our medium-size grants. These proposals have two (or three smaller) aims that describe work requiring two years to complete. They might have only one PI with or without collaborators. They can be considered equivalent to an NIH R21 grant.
This grant award would total $270,000 over two years. Up to 10% in indirect costs may be requested. Indirect costs are included in the total budget of $270,000. Grants will be paid in US dollars.
The Neuroendocrine Tumor Research Foundation (NETRF) seeks investigators and teams with the tools to study neuroendocrine cancers in innovative and transformative ways.
- Applicants must have a faculty appointment or equivalent position (assistant professor and above). Research track faculty are eligible to apply.
- Applicants must have the skills, knowledge, and resources necessary to carry out the proposed research.
- Applicants must have an MD, PhD, MD/PhD or equivalent degree.
- Eligible organizations include public or private institutions, such as universities, colleges, hospitals, and laboratories, both domestic and international.
- Projects that bring together investigators from diverse scientific disciplines are highly encouraged. For team applications, one recipient principal investigator and recipient institution must be selected. International applications are welcome.
- Awardees, as a condition of acceptance, will be required to attend the annual NETRF Research Symposium. Funds from the awarded grant should be allocated to attend the Annual NETRF Symposium.
NETRF will recruit for Investigator Award applications as part of our annual Request for Applications (RFA). Letters of Intent (LOI) are reviewed by the NETRF Board of Scientific Advisors, with applicants invited to submit full applications based on the quality of the project, support from the applicant’s institution, budget, and potential of the research to advance the field.
Grant recipients are required to submit biannual reports detailing scientific progress, research milestones achieved, and financial expenditures related to the project. The reports disclose updates on publications, patents and clinical trial advances when applicable. These reports are reviewed by NETRF’s Scientific Review and Grants Administration team to ensure that funds are being properly spent and that sufficient progress is made throughout the grant term. Continued funding is contingent upon review and approval of progress and achievement of relevant milestones. Post-award reports at one, three and five years are required to measure longer-term outcomes of the funded research.